Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events rti hs webinar lessons learned review fda pro labeling
… RTI-HS Webinar - Lessons Learned From a Review of FDA PRO Labeling Share on: …
… Webinar: Characteristics of Recent PRO Labeling by the FDA and EMA for Oncology Drugs Share on: Wednesday, March 13 … Based on Patient-Reported Outcomes (PROs) A recent review of labels from drugs approved by the European …
… Careers at RTI-HS We invite you to learn more about our company and our … they have to say about a variety of aspects of working at RTI-HS by browsing the categories above. Then view our open …
… RTI-HS researcher to lead study that will seek perspectives of … Senior Economist and VP of Health Preference Assessment at RTI-HS, will lead the AD PACE What Matters Most study that is the …
… regulatory negotiations. Our team has negotiated with the FDA’s Clinical Outcome Assessments (COA) team and a wide … acceptable to the FDA following the release of the FDA’s PRO Guidance. To support these efforts, we have developed … clients to FDA meetings in support of their proposed labeling claims. Our experts, particularly those based in …
… Webinar: Advanced Network Meta-analysis Share on: Thursday, … and how they are received by regulatory agencies such as FDA and EMA. Join us as our panel of experts discusses some …
… Webinar: Addressing Challenges in Health Equity Research … reviews and distributional cost-effectiveness analysis Review social determinants data and tools to leverage in health equity research: introducing RTI Rarity™ Who Should Attend Individuals involved in the …
… COVID-19 Vaccine Development Share on: November 11, 2021 RTI-HS is collaborating with the FDA to ensure that rigorous, … studies. Panelists and moderators emphasized how lessons learned during the COVID-19 pandemic can prepare us …
… Webinar: Common Challenges & Solutions in Analysis of PROs in … analyzing, and interpreting patient-reported outcome (PRO) data for oncology trials can present unique challenges. …
… RTI-HS Researchers Outline Best Practices for Collecting Patient … outcome assessment (COA) data. They drew on current FDA recommendations for patient-focused drug development …